AxioMed Opens $10MM Funding Round

Following closure of an oversubscribed first round, AxioMed opened a US $10MM round of funding to support operations and ex-U.S. sales.

In 1Q17, the company completed collection and analysis of 2-year follow-up data in its U.S. Investigational Device Exemption (IDE) clinical study of its viscoelastic lumbar disc....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us